H.B. Fuller (NYSE:FUL - Get Free Report) had its target price lowered by JPMorgan Chase & Co. from $70.00 to $60.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage presently has an "underweight" rating on the specialty chemicals company's stock. JPMorgan Chase & Co.'s price target would indicate a potential downside of 3.44% from the stock's previous close.
Several other analysts have also issued reports on FUL. Vertical Research lowered H.B. Fuller from a "buy" rating to a "hold" rating in a report on Monday, January 6th. Citigroup lowered their target price on shares of H.B. Fuller from $78.00 to $68.00 and set a "neutral" rating on the stock in a report on Friday, January 3rd. One analyst has rated the stock with a sell rating, four have issued a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $84.20.
Get Our Latest Research Report on FUL
H.B. Fuller Stock Down 0.1 %
FUL traded down $0.08 during trading on Friday, hitting $62.14. The company had a trading volume of 636,285 shares, compared to its average volume of 352,560. The firm's 50-day moving average price is $70.82 and its 200 day moving average price is $76.79. The company has a market capitalization of $3.39 billion, a PE ratio of 19.18, a PEG ratio of 1.50 and a beta of 1.43. The company has a quick ratio of 1.16, a current ratio of 1.89 and a debt-to-equity ratio of 1.10. H.B. Fuller has a one year low of $60.96 and a one year high of $87.67.
H.B. Fuller (NYSE:FUL - Get Free Report) last posted its quarterly earnings data on Wednesday, January 15th. The specialty chemicals company reported $0.92 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.00 by ($0.08). The firm had revenue of $923.00 million for the quarter, compared to the consensus estimate of $916.84 million. H.B. Fuller had a return on equity of 13.39% and a net margin of 5.15%. The firm's quarterly revenue was up 2.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.32 earnings per share. As a group, equities analysts expect that H.B. Fuller will post 3.84 earnings per share for the current year.
Institutional Investors Weigh In On H.B. Fuller
A number of large investors have recently added to or reduced their stakes in the business. S&CO Inc. grew its holdings in H.B. Fuller by 0.3% in the 3rd quarter. S&CO Inc. now owns 267,192 shares of the specialty chemicals company's stock valued at $21,209,000 after buying an additional 920 shares in the last quarter. Wesbanco Bank Inc. raised its stake in H.B. Fuller by 41.2% in the 4th quarter. Wesbanco Bank Inc. now owns 13,700 shares of the specialty chemicals company's stock worth $924,000 after purchasing an additional 4,000 shares in the last quarter. Geode Capital Management LLC boosted its holdings in H.B. Fuller by 1.5% in the 3rd quarter. Geode Capital Management LLC now owns 1,258,752 shares of the specialty chemicals company's stock valued at $99,939,000 after purchasing an additional 18,734 shares during the period. Marshall Wace LLP grew its position in shares of H.B. Fuller by 9.9% during the 2nd quarter. Marshall Wace LLP now owns 290,005 shares of the specialty chemicals company's stock worth $22,319,000 after purchasing an additional 26,239 shares in the last quarter. Finally, Lord Abbett & CO. LLC increased its holdings in shares of H.B. Fuller by 79.8% during the third quarter. Lord Abbett & CO. LLC now owns 730,058 shares of the specialty chemicals company's stock worth $57,952,000 after purchasing an additional 324,056 shares during the period. Institutional investors own 95.93% of the company's stock.
About H.B. Fuller
(
Get Free Report)
H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.
See Also
Before you consider H.B. Fuller, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and H.B. Fuller wasn't on the list.
While H.B. Fuller currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.